These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

716 related items for PubMed ID: 8102797

  • 1. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.
    LaHoste GJ, Yu J, Marshall JF.
    Proc Natl Acad Sci U S A; 1993 Aug 15; 90(16):7451-5. PubMed ID: 8102797
    [Abstract] [Full Text] [Related]

  • 2. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep 15; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 3. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT, Brooderson RJ, White FJ.
    Neuroscience; 1992 Sep 15; 50(1):137-47. PubMed ID: 1357592
    [Abstract] [Full Text] [Related]

  • 4. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
    Paul ML, Graybiel AM, David JC, Robertson HA.
    J Neurosci; 1992 Oct 15; 12(10):3729-42. PubMed ID: 1357113
    [Abstract] [Full Text] [Related]

  • 5. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE, Yates TM.
    Neuroscience; 1999 Oct 15; 94(2):505-14. PubMed ID: 10579212
    [Abstract] [Full Text] [Related]

  • 6. Dopamine D2 receptor control of pallidal fos expression: comparisons between intact and 6-hydroxydopamine-treated hemispheres.
    Marshall JF, Cole BN, LaHoste GJ.
    Brain Res; 1993 Dec 31; 632(1-2):308-13. PubMed ID: 7908600
    [Abstract] [Full Text] [Related]

  • 7. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 31; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 8. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression.
    Keefe KA, Gerfen CR.
    Neuroscience; 1995 Jun 31; 66(4):903-13. PubMed ID: 7651617
    [Abstract] [Full Text] [Related]

  • 9. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
    Paul ML, Currie RW, Robertson HA.
    Neuroscience; 1995 May 31; 66(2):347-59. PubMed ID: 7477877
    [Abstract] [Full Text] [Related]

  • 10. Rapid development of D1 and D2 dopamine receptor supersensitivity as indicated by striatal and pallidal Fos expression.
    LaHoste GJ, Marshall JF.
    Neurosci Lett; 1994 Sep 26; 179(1-2):153-6. PubMed ID: 7845612
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM, Marin C, Susel Z, Chase TN.
    Eur J Pharmacol; 1993 Jun 04; 236(3):385-93. PubMed ID: 8102970
    [Abstract] [Full Text] [Related]

  • 12. Reserpine increases Fos activity in the rat basal ganglia via a quinpirole-sensitive mechanism.
    Cole DG, Di Figlia M.
    Neuroscience; 1994 May 04; 60(1):115-23. PubMed ID: 7914358
    [Abstract] [Full Text] [Related]

  • 13. Cerebrocortical Fos expression following dopaminergic stimulation: D1/D2 synergism and its breakdown.
    LaHoste GJ, Ruskin DN, Marshall JF.
    Brain Res; 1996 Jul 22; 728(1):97-104. PubMed ID: 8864302
    [Abstract] [Full Text] [Related]

  • 14. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.
    Hu XT, Wachtel SR, Galloway MP, White FJ.
    J Neurosci; 1990 Jul 22; 10(7):2318-29. PubMed ID: 1973947
    [Abstract] [Full Text] [Related]

  • 15. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT, White FJ.
    Synapse; 1994 May 22; 17(1):43-61. PubMed ID: 7913772
    [Abstract] [Full Text] [Related]

  • 16. Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin.
    Engber TM, Boldry RC, Kuo S, Chase TN.
    Brain Res; 1992 May 29; 581(2):261-8. PubMed ID: 1356580
    [Abstract] [Full Text] [Related]

  • 17. Differential regulation of release of acetylcholine in the striatum in mice following continuous exposure to selective D1 and D2 dopaminergic agonists.
    Wang HY, Zhou LW, Friedman E, Weiss B.
    Neuropharmacology; 1993 Jan 29; 32(1):85-91. PubMed ID: 8094235
    [Abstract] [Full Text] [Related]

  • 18. Interactive effects of stimulation of D1 and D2 dopamine receptors on fos-like immunoreactivity in the normosensitive rat striatum.
    Wirtshafter D, Asin KE.
    Brain Res Bull; 1994 Jan 29; 35(1):85-91. PubMed ID: 7953762
    [Abstract] [Full Text] [Related]

  • 19. Pressure reversed extracellular striatal dopamine decrease produced by D1 receptor agonist SKF 38393, and D2 receptor agonist LY 171555, but failed to change the effect of the activation of both D1 and D2 receptors.
    Abraini JH, Fechtali T, Rostain JC.
    Neuroscience; 1992 Sep 29; 50(2):395-402. PubMed ID: 1359460
    [Abstract] [Full Text] [Related]

  • 20. D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
    Pollack AE, Thomas LI.
    Pharmacol Biochem Behav; 2010 Jan 29; 94(3):346-51. PubMed ID: 19800912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.